Bioactive prenylated c6–c3 derivatives from the roots of Illicium brevistylum

Jing-Yu Zhang,Hui-Lin Yang,Wen-Rui Li,Rong-Mei Gao,Mi Li,Ru-Bing Wang,Jia Yang,Qian-Ru Wang,Yu-Huan Li,Li Li,Shuang-Gang Ma
DOI: https://doi.org/10.1080/10286020.2024.2365437
2024-06-19
Journal of Asian Natural Products Research
Abstract:Three new prenylated C 6 –C 3 compounds ( 1–3 ), together with two known prenylated C 6 –C 3 compounds ( 4–5 ) and one known C 6 –C 3 derivative ( 6 ), were isolated from the roots of Illicium brevistylum A. C. Smith. The structures of 1–3 were elucidated by spectroscopic methods including 1D and 2D NMR, HRESIMS, CD experiments and ECD calculations. The structure of illibrefunone A ( 1 ) was confirmed by single-crystal X-ray diffraction analysis. All compounds were evaluated in terms of their anti-inflammatory potential on nitric oxide (NO) generation in lipopolysaccharide-stimulated murine RAW264.7 macrophages and murine BV2 microglial cells, antiviral activity against Coxsackievirus B3 (CVB3) and influenza virus A/Hanfang/359/95 (H3N2). Compounds 3 and 4 exhibited potent inhibitory effects on the production of NO in RAW 264.7 cells with IC 50 values of 20.57 and 12.87 μM respectively, which were greater than those of dexamethasone (positive control). Compounds 1 and 4–6 exhibited weak activity against Coxsackievirus B3, with IC 50 values ranging from 25.87 to 33.33 μM.
pharmacology & pharmacy,chemistry, medicinal, applied,plant sciences
What problem does this paper attempt to address?